clinicaltrials.gov

Vir RSS za ClinicalTrials.gov: adalimumab | Recruiting, Not yet recruiting, Active, not recruiting, Enrolling by invitation Studies | Interventional Studies | Phase Early Phase 1, 1, 2, 3, 4 | Industry | Last update posted in the last 14 days

Q: Kateri je URL vira RSS za ClinicalTrials.gov: adalimumab | Recruiting, Not yet recruiting, Active, not recruiting, Enrolling by invitation Studies | Interventional Studies | Phase Early Phase 1, 1, 2, 3, 4 | Industry | Last update posted in the last 14 days?

Naslov vira je https://clinicaltrials.gov/ct2/results/rss.xml?rcv_d=&lup_d=14&sel_rss=mod14&term=adalimumab&recrs=abdf&type=Intr&phase=01234&fund=2&count=10000. Prilepite ga v kateri koli bralnik RSS ali kliknite Spremljaj zdaj, da ga boste brali v aplikaciji Feeder.

Q: Ali vir RSS ClinicalTrials.gov: adalimumab | Recruiting, Not yet recruiting, Active, not recruiting, Enrolling by invitation Studies | Interventional Studies | Phase Early Phase 1, 1, 2, 3, 4 | Industry | Last update posted in the last 14 days deluje?

Da. Feeder ga je preveril pred okoli 1 ura in vir se je normalno odzval.

Q: Kako lahko spremljam ClinicalTrials.gov: adalimumab | Recruiting, Not yet recruiting, Active, not recruiting, Enrolling by invitation Studies | Interventional Studies | Phase Early Phase 1, 1, 2, 3, 4 | Industry | Last update posted in the last 14 days v aplikaciji Feeder?

Kliknite Spremljaj zdaj in se registrirajte, če še nimate računa. Brezplačni paket Feeder vključuje do 200 virov v spletu ter napravah iPhone in Android. Kreditna kartica ni potrebna.

Prejemaj najnovejše posodobitve iz ClinicalTrials.gov: adalimumab | Recruiting, Not yet recruiting, Active, not recruiting, Enrolling by invitation Studies | Interventional Studies | Phase Early Phase 1, 1, 2, 3, 4 | Industry | Last update posted in the last 14 days takoj, ko se zgodijo.

Spremljaj zdaj < 10 sledilcev

O tem viru

Clinical trial listings for adalimumab and related studies in various inflammatory diseases.

Stanje: Deluje Preverjeno pred okoli 1 ura, vsakih okoli 2 uri
Objave: Približno 2-krat na teden Zadnja objava pred okoli 9 ur
Jezik: English
Sledilci: < 10
Spletno mesto: clinicaltrials.gov
URL vira RSS: https://clinicaltrials.gov/ct2/results/rss.xml?rcv_d=&lup_d=14&sel_rss=mod14&term=adalimumab&recrs=abdf&type=Intr&phase=01234&fund=2&count=10000

Preverite ta vir z validatorjem RSS

Poiščite vir RSS drugega spletnega mesta

Najnovejše objave

Berite ClinicalTrials.gov: adalimumab | Recruiting, Not yet recruiting, Active, not recruiting, Enrolling by invitation Studies | Interventional Studies | Phase Early Phase 1, 1, 2, 3, 4 | Industry | Last update posted in the last 14 days tam, kjer sicer berete

Sledite v aplikaciji Feeder Berite ga skupaj z vsem drugim, čemur sledite, v spletu, na iPhonu in v sistemu Android. E-poštni novičniki Svoje branje spremenite v novičnik, ne da bi zapustili Feeder. RSS v Telegram Vaši viri, dostavljeni na Telegram. Nahranite svojo umetno inteligenco Povežite Claude, ChatGPT in Cursor s svojimi viri prek MCP-ja Povzetki z AI Ujemite bistvo, z viri za preverjanje. Pretvorba besedila v govor Spremenite svoj bralni seznam v podcast.

Vprašanja

Kateri je URL vira RSS za ClinicalTrials.gov: adalimumab | Recruiting, Not yet recruiting, Active, not recruiting, Enrolling by invitation Studies | Interventional Studies | Phase Early Phase 1, 1, 2, 3, 4 | Industry | Last update posted in the last 14 days?

Naslov vira je https://clinicaltrials.gov/ct2/results/rss.xml?rcv_d=&lup_d=14&sel_rss=mod14&term=adalimumab&recrs=abdf&type=Intr&phase=01234&fund=2&count=10000. Prilepite ga v kateri koli bralnik RSS ali kliknite Spremljaj zdaj, da ga boste brali v aplikaciji Feeder.

Kako pogosto objavlja ClinicalTrials.gov: adalimumab | Recruiting, Not yet recruiting, Active, not recruiting, Enrolling by invitation Studies | Interventional Studies | Phase Early Phase 1, 1, 2, 3, 4 | Industry | Last update posted in the last 14 days?

ClinicalTrials.gov: adalimumab | Recruiting, Not yet recruiting, Active, not recruiting, Enrolling by invitation Studies | Interventional Studies | Phase Early Phase 1, 1, 2, 3, 4 | Industry | Last update posted in the last 14 days objavlja približno 2-krat na teden. Zadnja objava je bila objavljena pred okoli 9 ur.

Ali vir RSS ClinicalTrials.gov: adalimumab | Recruiting, Not yet recruiting, Active, not recruiting, Enrolling by invitation Studies | Interventional Studies | Phase Early Phase 1, 1, 2, 3, 4 | Industry | Last update posted in the last 14 days deluje?

Da. Feeder ga je preveril pred okoli 1 ura in vir se je normalno odzval.

Kako lahko spremljam ClinicalTrials.gov: adalimumab | Recruiting, Not yet recruiting, Active, not recruiting, Enrolling by invitation Studies | Interventional Studies | Phase Early Phase 1, 1, 2, 3, 4 | Industry | Last update posted in the last 14 days v aplikaciji Feeder?

Kliknite Spremljaj zdaj in se registrirajte, če še nimate računa. Brezplačni paket Feeder vključuje do 200 virov v spletu ter napravah iPhone in Android. Kreditna kartica ni potrebna.

Spremljajte ClinicalTrials.gov: adalimumab | Recruiting, Not yet recruiting, Active, not recruiting, Enrolling by invitation Studies | Interventional Studies | Phase Early Phase 1, 1, 2, 3, 4 | Industry | Last update posted in the last 14 days v aplikaciji Feeder

Brezplačni paket Feeder vključuje do 200 virov v spletu ter napravah iPhone in Android. Kreditna kartica ni potrebna.

Prijavi se brezplačno

Ali pa se prijavite